[ Price : $8.95]
FDA issues a safety warning about certain brands of ultraviolet wands used for disinfecting surfaces because the devices may expos...[ Price : $8.95]
The Veeva Field Trends 2022 report says 75% of healthcare providers want contact with drug field staff to be a mix of digital and ...[ Price : $8.95]
FDA clears a Neuronetics 510(k) for a new indication for its NeuroStar Advanced Therapy for Mental Health device, a transcranial m...[ Price : $8.95]
FDA warns Spains Bioiberica about CGMP deviations in its manufacturing of active pharmaceutical ingredients.[ Price : $8.95]
FDA warns Imprimis Rx that professional promotional materials for a compounded ophthalmic drug make false and misleading statement...[ Price : $8.95]
FDA lifts a clinical hold against Viking Therapeutics VK0214 in patients with X-linked adrenoleukodystrophy.[ Price : $8.95]
Merck halts a Phase 3 LYNK-003 trial investigating Lynparza (olaparib) with or without bevacizumab for treating patients with unre...[ Price : $8.95]
CDER director Patrizia Cavazzoni selects associate director for controlled substances Marta Sokolowska to serve as deputy Center d...